Developments USPTO issues NOA for Purple’s next-gen multispecific antibody platform Purple Biotech (NASDAQ/TASE: PPBT) has announced that the U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance (NOA) for a patent application covering tri-specific antibody constructs and methods of use... September 2, 2026